Global Biopharmaceutical CDMO Service Supply, Demand and Key Producers, 2023-2029
The global Biopharmaceutical CDMO Service market size is expected to reach $ 29010 million by 2029, rising at a market growth of 9.8% CAGR during the forecast period (2023-2029).
This report studies the global Biopharmaceutical CDMO Service demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Biopharmaceutical CDMO Service, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Biopharmaceutical CDMO Service that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Biopharmaceutical CDMO Service total market, 2018-2029, (USD Million)
Global Biopharmaceutical CDMO Service total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Biopharmaceutical CDMO Service total market, key domestic companies and share, (USD Million)
Global Biopharmaceutical CDMO Service revenue by player and market share 2018-2023, (USD Million)
Global Biopharmaceutical CDMO Service total market by Type, CAGR, 2018-2029, (USD Million)
Global Biopharmaceutical CDMO Service total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Biopharmaceutical CDMO Service market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include KBI Biopharma, INCOG BioPharma Services, CordenPharma, AGC Biologics, Northway Biotech, PlantForm Corp, Lonza, ADL Biopharma and Catalent, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Biopharmaceutical CDMO Service market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Biopharmaceutical CDMO Service Market, By Region:
1. How big is the global Biopharmaceutical CDMO Service market?
2. What is the demand of the global Biopharmaceutical CDMO Service market?
3. What is the year over year growth of the global Biopharmaceutical CDMO Service market?
4. What is the total value of the global Biopharmaceutical CDMO Service market?
5. Who are the major players in the global Biopharmaceutical CDMO Service market?
This report studies the global Biopharmaceutical CDMO Service demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Biopharmaceutical CDMO Service, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Biopharmaceutical CDMO Service that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Biopharmaceutical CDMO Service total market, 2018-2029, (USD Million)
Global Biopharmaceutical CDMO Service total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Biopharmaceutical CDMO Service total market, key domestic companies and share, (USD Million)
Global Biopharmaceutical CDMO Service revenue by player and market share 2018-2023, (USD Million)
Global Biopharmaceutical CDMO Service total market by Type, CAGR, 2018-2029, (USD Million)
Global Biopharmaceutical CDMO Service total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Biopharmaceutical CDMO Service market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include KBI Biopharma, INCOG BioPharma Services, CordenPharma, AGC Biologics, Northway Biotech, PlantForm Corp, Lonza, ADL Biopharma and Catalent, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Biopharmaceutical CDMO Service market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Biopharmaceutical CDMO Service Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Develop Innovative Drugs
- Listed Patented Drug
- Biosimilars
- Others
- Pharmaceutical Company
- Biotechnology Company
- Others
- KBI Biopharma
- INCOG BioPharma Services
- CordenPharma
- AGC Biologics
- Northway Biotech
- PlantForm Corp
- Lonza
- ADL Biopharma
- Catalent
- Future Fields
- Vetter Pharma
- Stelis
- Richter-Helm
- FUJIFILM Diosynth Biotechnologies
- Cambrex
- Pfizer CentreOne
- Samsung Biologics
1. How big is the global Biopharmaceutical CDMO Service market?
2. What is the demand of the global Biopharmaceutical CDMO Service market?
3. What is the year over year growth of the global Biopharmaceutical CDMO Service market?
4. What is the total value of the global Biopharmaceutical CDMO Service market?
5. Who are the major players in the global Biopharmaceutical CDMO Service market?
1 SUPPLY SUMMARY
1.1 Biopharmaceutical CDMO Service Introduction
1.2 World Biopharmaceutical CDMO Service Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Biopharmaceutical CDMO Service Total Market by Region (by Headquarter Location)
1.3.1 World Biopharmaceutical CDMO Service Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Biopharmaceutical CDMO Service Market Size (2018-2029)
1.3.3 China Biopharmaceutical CDMO Service Market Size (2018-2029)
1.3.4 Europe Biopharmaceutical CDMO Service Market Size (2018-2029)
1.3.5 Japan Biopharmaceutical CDMO Service Market Size (2018-2029)
1.3.6 South Korea Biopharmaceutical CDMO Service Market Size (2018-2029)
1.3.7 ASEAN Biopharmaceutical CDMO Service Market Size (2018-2029)
1.3.8 India Biopharmaceutical CDMO Service Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Biopharmaceutical CDMO Service Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Biopharmaceutical CDMO Service Major Market Trends
2 DEMAND SUMMARY
2.1 World Biopharmaceutical CDMO Service Consumption Value (2018-2029)
2.2 World Biopharmaceutical CDMO Service Consumption Value by Region
2.2.1 World Biopharmaceutical CDMO Service Consumption Value by Region (2018-2023)
2.2.2 World Biopharmaceutical CDMO Service Consumption Value Forecast by Region (2024-2029)
2.3 United States Biopharmaceutical CDMO Service Consumption Value (2018-2029)
2.4 China Biopharmaceutical CDMO Service Consumption Value (2018-2029)
2.5 Europe Biopharmaceutical CDMO Service Consumption Value (2018-2029)
2.6 Japan Biopharmaceutical CDMO Service Consumption Value (2018-2029)
2.7 South Korea Biopharmaceutical CDMO Service Consumption Value (2018-2029)
2.8 ASEAN Biopharmaceutical CDMO Service Consumption Value (2018-2029)
2.9 India Biopharmaceutical CDMO Service Consumption Value (2018-2029)
3 WORLD BIOPHARMACEUTICAL CDMO SERVICE COMPANIES COMPETITIVE ANALYSIS
3.1 World Biopharmaceutical CDMO Service Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Biopharmaceutical CDMO Service Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Biopharmaceutical CDMO Service in 2022
3.2.3 Global Concentration Ratios (CR8) for Biopharmaceutical CDMO Service in 2022
3.3 Biopharmaceutical CDMO Service Company Evaluation Quadrant
3.4 Biopharmaceutical CDMO Service Market: Overall Company Footprint Analysis
3.4.1 Biopharmaceutical CDMO Service Market: Region Footprint
3.4.2 Biopharmaceutical CDMO Service Market: Company Product Type Footprint
3.4.3 Biopharmaceutical CDMO Service Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Biopharmaceutical CDMO Service Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Biopharmaceutical CDMO Service Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Biopharmaceutical CDMO Service Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Biopharmaceutical CDMO Service Consumption Value Comparison
4.2.1 United States VS China: Biopharmaceutical CDMO Service Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Biopharmaceutical CDMO Service Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Biopharmaceutical CDMO Service Companies and Market Share, 2018-2023
4.3.1 United States Based Biopharmaceutical CDMO Service Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Biopharmaceutical CDMO Service Revenue, (2018-2023)
4.4 China Based Companies Biopharmaceutical CDMO Service Revenue and Market Share, 2018-2023
4.4.1 China Based Biopharmaceutical CDMO Service Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Biopharmaceutical CDMO Service Revenue, (2018-2023)
4.5 Rest of World Based Biopharmaceutical CDMO Service Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Biopharmaceutical CDMO Service Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Biopharmaceutical CDMO Service Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Biopharmaceutical CDMO Service Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Develop Innovative Drugs
5.2.2 Listed Patented Drug
5.2.3 Biosimilars
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Biopharmaceutical CDMO Service Market Size by Type (2018-2023)
5.3.2 World Biopharmaceutical CDMO Service Market Size by Type (2024-2029)
5.3.3 World Biopharmaceutical CDMO Service Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Biopharmaceutical CDMO Service Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Pharmaceutical Company
6.2.2 Biotechnology Company
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Biopharmaceutical CDMO Service Market Size by Application (2018-2023)
6.3.2 World Biopharmaceutical CDMO Service Market Size by Application (2024-2029)
6.3.3 World Biopharmaceutical CDMO Service Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 KBI Biopharma
7.1.1 KBI Biopharma Details
7.1.2 KBI Biopharma Major Business
7.1.3 KBI Biopharma Biopharmaceutical CDMO Service Product and Services
7.1.4 KBI Biopharma Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 KBI Biopharma Recent Developments/Updates
7.1.6 KBI Biopharma Competitive Strengths & Weaknesses
7.2 INCOG BioPharma Services
7.2.1 INCOG BioPharma Services Details
7.2.2 INCOG BioPharma Services Major Business
7.2.3 INCOG BioPharma Services Biopharmaceutical CDMO Service Product and Services
7.2.4 INCOG BioPharma Services Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 INCOG BioPharma Services Recent Developments/Updates
7.2.6 INCOG BioPharma Services Competitive Strengths & Weaknesses
7.3 CordenPharma
7.3.1 CordenPharma Details
7.3.2 CordenPharma Major Business
7.3.3 CordenPharma Biopharmaceutical CDMO Service Product and Services
7.3.4 CordenPharma Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 CordenPharma Recent Developments/Updates
7.3.6 CordenPharma Competitive Strengths & Weaknesses
7.4 AGC Biologics
7.4.1 AGC Biologics Details
7.4.2 AGC Biologics Major Business
7.4.3 AGC Biologics Biopharmaceutical CDMO Service Product and Services
7.4.4 AGC Biologics Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 AGC Biologics Recent Developments/Updates
7.4.6 AGC Biologics Competitive Strengths & Weaknesses
7.5 Northway Biotech
7.5.1 Northway Biotech Details
7.5.2 Northway Biotech Major Business
7.5.3 Northway Biotech Biopharmaceutical CDMO Service Product and Services
7.5.4 Northway Biotech Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Northway Biotech Recent Developments/Updates
7.5.6 Northway Biotech Competitive Strengths & Weaknesses
7.6 PlantForm Corp
7.6.1 PlantForm Corp Details
7.6.2 PlantForm Corp Major Business
7.6.3 PlantForm Corp Biopharmaceutical CDMO Service Product and Services
7.6.4 PlantForm Corp Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 PlantForm Corp Recent Developments/Updates
7.6.6 PlantForm Corp Competitive Strengths & Weaknesses
7.7 Lonza
7.7.1 Lonza Details
7.7.2 Lonza Major Business
7.7.3 Lonza Biopharmaceutical CDMO Service Product and Services
7.7.4 Lonza Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Lonza Recent Developments/Updates
7.7.6 Lonza Competitive Strengths & Weaknesses
7.8 ADL Biopharma
7.8.1 ADL Biopharma Details
7.8.2 ADL Biopharma Major Business
7.8.3 ADL Biopharma Biopharmaceutical CDMO Service Product and Services
7.8.4 ADL Biopharma Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 ADL Biopharma Recent Developments/Updates
7.8.6 ADL Biopharma Competitive Strengths & Weaknesses
7.9 Catalent
7.9.1 Catalent Details
7.9.2 Catalent Major Business
7.9.3 Catalent Biopharmaceutical CDMO Service Product and Services
7.9.4 Catalent Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Catalent Recent Developments/Updates
7.9.6 Catalent Competitive Strengths & Weaknesses
7.10 Future Fields
7.10.1 Future Fields Details
7.10.2 Future Fields Major Business
7.10.3 Future Fields Biopharmaceutical CDMO Service Product and Services
7.10.4 Future Fields Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Future Fields Recent Developments/Updates
7.10.6 Future Fields Competitive Strengths & Weaknesses
7.11 Vetter Pharma
7.11.1 Vetter Pharma Details
7.11.2 Vetter Pharma Major Business
7.11.3 Vetter Pharma Biopharmaceutical CDMO Service Product and Services
7.11.4 Vetter Pharma Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Vetter Pharma Recent Developments/Updates
7.11.6 Vetter Pharma Competitive Strengths & Weaknesses
7.12 Stelis
7.12.1 Stelis Details
7.12.2 Stelis Major Business
7.12.3 Stelis Biopharmaceutical CDMO Service Product and Services
7.12.4 Stelis Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Stelis Recent Developments/Updates
7.12.6 Stelis Competitive Strengths & Weaknesses
7.13 Richter-Helm
7.13.1 Richter-Helm Details
7.13.2 Richter-Helm Major Business
7.13.3 Richter-Helm Biopharmaceutical CDMO Service Product and Services
7.13.4 Richter-Helm Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Richter-Helm Recent Developments/Updates
7.13.6 Richter-Helm Competitive Strengths & Weaknesses
7.14 FUJIFILM Diosynth Biotechnologies
7.14.1 FUJIFILM Diosynth Biotechnologies Details
7.14.2 FUJIFILM Diosynth Biotechnologies Major Business
7.14.3 FUJIFILM Diosynth Biotechnologies Biopharmaceutical CDMO Service Product and Services
7.14.4 FUJIFILM Diosynth Biotechnologies Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 FUJIFILM Diosynth Biotechnologies Recent Developments/Updates
7.14.6 FUJIFILM Diosynth Biotechnologies Competitive Strengths & Weaknesses
7.15 Cambrex
7.15.1 Cambrex Details
7.15.2 Cambrex Major Business
7.15.3 Cambrex Biopharmaceutical CDMO Service Product and Services
7.15.4 Cambrex Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Cambrex Recent Developments/Updates
7.15.6 Cambrex Competitive Strengths & Weaknesses
7.16 Pfizer CentreOne
7.16.1 Pfizer CentreOne Details
7.16.2 Pfizer CentreOne Major Business
7.16.3 Pfizer CentreOne Biopharmaceutical CDMO Service Product and Services
7.16.4 Pfizer CentreOne Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Pfizer CentreOne Recent Developments/Updates
7.16.6 Pfizer CentreOne Competitive Strengths & Weaknesses
7.17 Samsung Biologics
7.17.1 Samsung Biologics Details
7.17.2 Samsung Biologics Major Business
7.17.3 Samsung Biologics Biopharmaceutical CDMO Service Product and Services
7.17.4 Samsung Biologics Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Samsung Biologics Recent Developments/Updates
7.17.6 Samsung Biologics Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Biopharmaceutical CDMO Service Industry Chain
8.2 Biopharmaceutical CDMO Service Upstream Analysis
8.3 Biopharmaceutical CDMO Service Midstream Analysis
8.4 Biopharmaceutical CDMO Service Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Biopharmaceutical CDMO Service Introduction
1.2 World Biopharmaceutical CDMO Service Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Biopharmaceutical CDMO Service Total Market by Region (by Headquarter Location)
1.3.1 World Biopharmaceutical CDMO Service Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Biopharmaceutical CDMO Service Market Size (2018-2029)
1.3.3 China Biopharmaceutical CDMO Service Market Size (2018-2029)
1.3.4 Europe Biopharmaceutical CDMO Service Market Size (2018-2029)
1.3.5 Japan Biopharmaceutical CDMO Service Market Size (2018-2029)
1.3.6 South Korea Biopharmaceutical CDMO Service Market Size (2018-2029)
1.3.7 ASEAN Biopharmaceutical CDMO Service Market Size (2018-2029)
1.3.8 India Biopharmaceutical CDMO Service Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Biopharmaceutical CDMO Service Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Biopharmaceutical CDMO Service Major Market Trends
2 DEMAND SUMMARY
2.1 World Biopharmaceutical CDMO Service Consumption Value (2018-2029)
2.2 World Biopharmaceutical CDMO Service Consumption Value by Region
2.2.1 World Biopharmaceutical CDMO Service Consumption Value by Region (2018-2023)
2.2.2 World Biopharmaceutical CDMO Service Consumption Value Forecast by Region (2024-2029)
2.3 United States Biopharmaceutical CDMO Service Consumption Value (2018-2029)
2.4 China Biopharmaceutical CDMO Service Consumption Value (2018-2029)
2.5 Europe Biopharmaceutical CDMO Service Consumption Value (2018-2029)
2.6 Japan Biopharmaceutical CDMO Service Consumption Value (2018-2029)
2.7 South Korea Biopharmaceutical CDMO Service Consumption Value (2018-2029)
2.8 ASEAN Biopharmaceutical CDMO Service Consumption Value (2018-2029)
2.9 India Biopharmaceutical CDMO Service Consumption Value (2018-2029)
3 WORLD BIOPHARMACEUTICAL CDMO SERVICE COMPANIES COMPETITIVE ANALYSIS
3.1 World Biopharmaceutical CDMO Service Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Biopharmaceutical CDMO Service Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Biopharmaceutical CDMO Service in 2022
3.2.3 Global Concentration Ratios (CR8) for Biopharmaceutical CDMO Service in 2022
3.3 Biopharmaceutical CDMO Service Company Evaluation Quadrant
3.4 Biopharmaceutical CDMO Service Market: Overall Company Footprint Analysis
3.4.1 Biopharmaceutical CDMO Service Market: Region Footprint
3.4.2 Biopharmaceutical CDMO Service Market: Company Product Type Footprint
3.4.3 Biopharmaceutical CDMO Service Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Biopharmaceutical CDMO Service Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Biopharmaceutical CDMO Service Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Biopharmaceutical CDMO Service Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Biopharmaceutical CDMO Service Consumption Value Comparison
4.2.1 United States VS China: Biopharmaceutical CDMO Service Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Biopharmaceutical CDMO Service Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Biopharmaceutical CDMO Service Companies and Market Share, 2018-2023
4.3.1 United States Based Biopharmaceutical CDMO Service Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Biopharmaceutical CDMO Service Revenue, (2018-2023)
4.4 China Based Companies Biopharmaceutical CDMO Service Revenue and Market Share, 2018-2023
4.4.1 China Based Biopharmaceutical CDMO Service Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Biopharmaceutical CDMO Service Revenue, (2018-2023)
4.5 Rest of World Based Biopharmaceutical CDMO Service Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Biopharmaceutical CDMO Service Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Biopharmaceutical CDMO Service Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Biopharmaceutical CDMO Service Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Develop Innovative Drugs
5.2.2 Listed Patented Drug
5.2.3 Biosimilars
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Biopharmaceutical CDMO Service Market Size by Type (2018-2023)
5.3.2 World Biopharmaceutical CDMO Service Market Size by Type (2024-2029)
5.3.3 World Biopharmaceutical CDMO Service Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Biopharmaceutical CDMO Service Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Pharmaceutical Company
6.2.2 Biotechnology Company
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Biopharmaceutical CDMO Service Market Size by Application (2018-2023)
6.3.2 World Biopharmaceutical CDMO Service Market Size by Application (2024-2029)
6.3.3 World Biopharmaceutical CDMO Service Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 KBI Biopharma
7.1.1 KBI Biopharma Details
7.1.2 KBI Biopharma Major Business
7.1.3 KBI Biopharma Biopharmaceutical CDMO Service Product and Services
7.1.4 KBI Biopharma Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 KBI Biopharma Recent Developments/Updates
7.1.6 KBI Biopharma Competitive Strengths & Weaknesses
7.2 INCOG BioPharma Services
7.2.1 INCOG BioPharma Services Details
7.2.2 INCOG BioPharma Services Major Business
7.2.3 INCOG BioPharma Services Biopharmaceutical CDMO Service Product and Services
7.2.4 INCOG BioPharma Services Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 INCOG BioPharma Services Recent Developments/Updates
7.2.6 INCOG BioPharma Services Competitive Strengths & Weaknesses
7.3 CordenPharma
7.3.1 CordenPharma Details
7.3.2 CordenPharma Major Business
7.3.3 CordenPharma Biopharmaceutical CDMO Service Product and Services
7.3.4 CordenPharma Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 CordenPharma Recent Developments/Updates
7.3.6 CordenPharma Competitive Strengths & Weaknesses
7.4 AGC Biologics
7.4.1 AGC Biologics Details
7.4.2 AGC Biologics Major Business
7.4.3 AGC Biologics Biopharmaceutical CDMO Service Product and Services
7.4.4 AGC Biologics Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 AGC Biologics Recent Developments/Updates
7.4.6 AGC Biologics Competitive Strengths & Weaknesses
7.5 Northway Biotech
7.5.1 Northway Biotech Details
7.5.2 Northway Biotech Major Business
7.5.3 Northway Biotech Biopharmaceutical CDMO Service Product and Services
7.5.4 Northway Biotech Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Northway Biotech Recent Developments/Updates
7.5.6 Northway Biotech Competitive Strengths & Weaknesses
7.6 PlantForm Corp
7.6.1 PlantForm Corp Details
7.6.2 PlantForm Corp Major Business
7.6.3 PlantForm Corp Biopharmaceutical CDMO Service Product and Services
7.6.4 PlantForm Corp Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 PlantForm Corp Recent Developments/Updates
7.6.6 PlantForm Corp Competitive Strengths & Weaknesses
7.7 Lonza
7.7.1 Lonza Details
7.7.2 Lonza Major Business
7.7.3 Lonza Biopharmaceutical CDMO Service Product and Services
7.7.4 Lonza Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Lonza Recent Developments/Updates
7.7.6 Lonza Competitive Strengths & Weaknesses
7.8 ADL Biopharma
7.8.1 ADL Biopharma Details
7.8.2 ADL Biopharma Major Business
7.8.3 ADL Biopharma Biopharmaceutical CDMO Service Product and Services
7.8.4 ADL Biopharma Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 ADL Biopharma Recent Developments/Updates
7.8.6 ADL Biopharma Competitive Strengths & Weaknesses
7.9 Catalent
7.9.1 Catalent Details
7.9.2 Catalent Major Business
7.9.3 Catalent Biopharmaceutical CDMO Service Product and Services
7.9.4 Catalent Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Catalent Recent Developments/Updates
7.9.6 Catalent Competitive Strengths & Weaknesses
7.10 Future Fields
7.10.1 Future Fields Details
7.10.2 Future Fields Major Business
7.10.3 Future Fields Biopharmaceutical CDMO Service Product and Services
7.10.4 Future Fields Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Future Fields Recent Developments/Updates
7.10.6 Future Fields Competitive Strengths & Weaknesses
7.11 Vetter Pharma
7.11.1 Vetter Pharma Details
7.11.2 Vetter Pharma Major Business
7.11.3 Vetter Pharma Biopharmaceutical CDMO Service Product and Services
7.11.4 Vetter Pharma Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Vetter Pharma Recent Developments/Updates
7.11.6 Vetter Pharma Competitive Strengths & Weaknesses
7.12 Stelis
7.12.1 Stelis Details
7.12.2 Stelis Major Business
7.12.3 Stelis Biopharmaceutical CDMO Service Product and Services
7.12.4 Stelis Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Stelis Recent Developments/Updates
7.12.6 Stelis Competitive Strengths & Weaknesses
7.13 Richter-Helm
7.13.1 Richter-Helm Details
7.13.2 Richter-Helm Major Business
7.13.3 Richter-Helm Biopharmaceutical CDMO Service Product and Services
7.13.4 Richter-Helm Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Richter-Helm Recent Developments/Updates
7.13.6 Richter-Helm Competitive Strengths & Weaknesses
7.14 FUJIFILM Diosynth Biotechnologies
7.14.1 FUJIFILM Diosynth Biotechnologies Details
7.14.2 FUJIFILM Diosynth Biotechnologies Major Business
7.14.3 FUJIFILM Diosynth Biotechnologies Biopharmaceutical CDMO Service Product and Services
7.14.4 FUJIFILM Diosynth Biotechnologies Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 FUJIFILM Diosynth Biotechnologies Recent Developments/Updates
7.14.6 FUJIFILM Diosynth Biotechnologies Competitive Strengths & Weaknesses
7.15 Cambrex
7.15.1 Cambrex Details
7.15.2 Cambrex Major Business
7.15.3 Cambrex Biopharmaceutical CDMO Service Product and Services
7.15.4 Cambrex Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Cambrex Recent Developments/Updates
7.15.6 Cambrex Competitive Strengths & Weaknesses
7.16 Pfizer CentreOne
7.16.1 Pfizer CentreOne Details
7.16.2 Pfizer CentreOne Major Business
7.16.3 Pfizer CentreOne Biopharmaceutical CDMO Service Product and Services
7.16.4 Pfizer CentreOne Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Pfizer CentreOne Recent Developments/Updates
7.16.6 Pfizer CentreOne Competitive Strengths & Weaknesses
7.17 Samsung Biologics
7.17.1 Samsung Biologics Details
7.17.2 Samsung Biologics Major Business
7.17.3 Samsung Biologics Biopharmaceutical CDMO Service Product and Services
7.17.4 Samsung Biologics Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Samsung Biologics Recent Developments/Updates
7.17.6 Samsung Biologics Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Biopharmaceutical CDMO Service Industry Chain
8.2 Biopharmaceutical CDMO Service Upstream Analysis
8.3 Biopharmaceutical CDMO Service Midstream Analysis
8.4 Biopharmaceutical CDMO Service Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Biopharmaceutical CDMO Service Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Biopharmaceutical CDMO Service Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Biopharmaceutical CDMO Service Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Biopharmaceutical CDMO Service Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Biopharmaceutical CDMO Service Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Biopharmaceutical CDMO Service Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Biopharmaceutical CDMO Service Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Biopharmaceutical CDMO Service Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Biopharmaceutical CDMO Service Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Biopharmaceutical CDMO Service Players in 2022
Table 12. World Biopharmaceutical CDMO Service Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Biopharmaceutical CDMO Service Company Evaluation Quadrant
Table 14. Head Office of Key Biopharmaceutical CDMO Service Player
Table 15. Biopharmaceutical CDMO Service Market: Company Product Type Footprint
Table 16. Biopharmaceutical CDMO Service Market: Company Product Application Footprint
Table 17. Biopharmaceutical CDMO Service Mergers & Acquisitions Activity
Table 18. United States VS China Biopharmaceutical CDMO Service Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Biopharmaceutical CDMO Service Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Biopharmaceutical CDMO Service Companies, Headquarters (States, Country)
Table 21. United States Based Companies Biopharmaceutical CDMO Service Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Biopharmaceutical CDMO Service Revenue Market Share (2018-2023)
Table 23. China Based Biopharmaceutical CDMO Service Companies, Headquarters (Province, Country)
Table 24. China Based Companies Biopharmaceutical CDMO Service Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Biopharmaceutical CDMO Service Revenue Market Share (2018-2023)
Table 26. Rest of World Based Biopharmaceutical CDMO Service Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Biopharmaceutical CDMO Service Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Biopharmaceutical CDMO Service Revenue Market Share (2018-2023)
Table 29. World Biopharmaceutical CDMO Service Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Biopharmaceutical CDMO Service Market Size by Type (2018-2023) & (USD Million)
Table 31. World Biopharmaceutical CDMO Service Market Size by Type (2024-2029) & (USD Million)
Table 32. World Biopharmaceutical CDMO Service Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Biopharmaceutical CDMO Service Market Size by Application (2018-2023) & (USD Million)
Table 34. World Biopharmaceutical CDMO Service Market Size by Application (2024-2029) & (USD Million)
Table 35. KBI Biopharma Basic Information, Area Served and Competitors
Table 36. KBI Biopharma Major Business
Table 37. KBI Biopharma Biopharmaceutical CDMO Service Product and Services
Table 38. KBI Biopharma Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. KBI Biopharma Recent Developments/Updates
Table 40. KBI Biopharma Competitive Strengths & Weaknesses
Table 41. INCOG BioPharma Services Basic Information, Area Served and Competitors
Table 42. INCOG BioPharma Services Major Business
Table 43. INCOG BioPharma Services Biopharmaceutical CDMO Service Product and Services
Table 44. INCOG BioPharma Services Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. INCOG BioPharma Services Recent Developments/Updates
Table 46. INCOG BioPharma Services Competitive Strengths & Weaknesses
Table 47. CordenPharma Basic Information, Area Served and Competitors
Table 48. CordenPharma Major Business
Table 49. CordenPharma Biopharmaceutical CDMO Service Product and Services
Table 50. CordenPharma Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. CordenPharma Recent Developments/Updates
Table 52. CordenPharma Competitive Strengths & Weaknesses
Table 53. AGC Biologics Basic Information, Area Served and Competitors
Table 54. AGC Biologics Major Business
Table 55. AGC Biologics Biopharmaceutical CDMO Service Product and Services
Table 56. AGC Biologics Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. AGC Biologics Recent Developments/Updates
Table 58. AGC Biologics Competitive Strengths & Weaknesses
Table 59. Northway Biotech Basic Information, Area Served and Competitors
Table 60. Northway Biotech Major Business
Table 61. Northway Biotech Biopharmaceutical CDMO Service Product and Services
Table 62. Northway Biotech Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Northway Biotech Recent Developments/Updates
Table 64. Northway Biotech Competitive Strengths & Weaknesses
Table 65. PlantForm Corp Basic Information, Area Served and Competitors
Table 66. PlantForm Corp Major Business
Table 67. PlantForm Corp Biopharmaceutical CDMO Service Product and Services
Table 68. PlantForm Corp Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. PlantForm Corp Recent Developments/Updates
Table 70. PlantForm Corp Competitive Strengths & Weaknesses
Table 71. Lonza Basic Information, Area Served and Competitors
Table 72. Lonza Major Business
Table 73. Lonza Biopharmaceutical CDMO Service Product and Services
Table 74. Lonza Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Lonza Recent Developments/Updates
Table 76. Lonza Competitive Strengths & Weaknesses
Table 77. ADL Biopharma Basic Information, Area Served and Competitors
Table 78. ADL Biopharma Major Business
Table 79. ADL Biopharma Biopharmaceutical CDMO Service Product and Services
Table 80. ADL Biopharma Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. ADL Biopharma Recent Developments/Updates
Table 82. ADL Biopharma Competitive Strengths & Weaknesses
Table 83. Catalent Basic Information, Area Served and Competitors
Table 84. Catalent Major Business
Table 85. Catalent Biopharmaceutical CDMO Service Product and Services
Table 86. Catalent Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Catalent Recent Developments/Updates
Table 88. Catalent Competitive Strengths & Weaknesses
Table 89. Future Fields Basic Information, Area Served and Competitors
Table 90. Future Fields Major Business
Table 91. Future Fields Biopharmaceutical CDMO Service Product and Services
Table 92. Future Fields Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Future Fields Recent Developments/Updates
Table 94. Future Fields Competitive Strengths & Weaknesses
Table 95. Vetter Pharma Basic Information, Area Served and Competitors
Table 96. Vetter Pharma Major Business
Table 97. Vetter Pharma Biopharmaceutical CDMO Service Product and Services
Table 98. Vetter Pharma Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Vetter Pharma Recent Developments/Updates
Table 100. Vetter Pharma Competitive Strengths & Weaknesses
Table 101. Stelis Basic Information, Area Served and Competitors
Table 102. Stelis Major Business
Table 103. Stelis Biopharmaceutical CDMO Service Product and Services
Table 104. Stelis Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Stelis Recent Developments/Updates
Table 106. Stelis Competitive Strengths & Weaknesses
Table 107. Richter-Helm Basic Information, Area Served and Competitors
Table 108. Richter-Helm Major Business
Table 109. Richter-Helm Biopharmaceutical CDMO Service Product and Services
Table 110. Richter-Helm Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Richter-Helm Recent Developments/Updates
Table 112. Richter-Helm Competitive Strengths & Weaknesses
Table 113. FUJIFILM Diosynth Biotechnologies Basic Information, Area Served and Competitors
Table 114. FUJIFILM Diosynth Biotechnologies Major Business
Table 115. FUJIFILM Diosynth Biotechnologies Biopharmaceutical CDMO Service Product and Services
Table 116. FUJIFILM Diosynth Biotechnologies Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. FUJIFILM Diosynth Biotechnologies Recent Developments/Updates
Table 118. FUJIFILM Diosynth Biotechnologies Competitive Strengths & Weaknesses
Table 119. Cambrex Basic Information, Area Served and Competitors
Table 120. Cambrex Major Business
Table 121. Cambrex Biopharmaceutical CDMO Service Product and Services
Table 122. Cambrex Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Cambrex Recent Developments/Updates
Table 124. Cambrex Competitive Strengths & Weaknesses
Table 125. Pfizer CentreOne Basic Information, Area Served and Competitors
Table 126. Pfizer CentreOne Major Business
Table 127. Pfizer CentreOne Biopharmaceutical CDMO Service Product and Services
Table 128. Pfizer CentreOne Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Pfizer CentreOne Recent Developments/Updates
Table 130. Samsung Biologics Basic Information, Area Served and Competitors
Table 131. Samsung Biologics Major Business
Table 132. Samsung Biologics Biopharmaceutical CDMO Service Product and Services
Table 133. Samsung Biologics Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 134. Global Key Players of Biopharmaceutical CDMO Service Upstream (Raw Materials)
Table 135. Biopharmaceutical CDMO Service Typical Customers
List of Figure
Figure 1. Biopharmaceutical CDMO Service Picture
Figure 2. World Biopharmaceutical CDMO Service Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Biopharmaceutical CDMO Service Total Market Size (2018-2029) & (USD Million)
Figure 4. World Biopharmaceutical CDMO Service Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Biopharmaceutical CDMO Service Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Biopharmaceutical CDMO Service Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Biopharmaceutical CDMO Service Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Biopharmaceutical CDMO Service Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Biopharmaceutical CDMO Service Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Biopharmaceutical CDMO Service Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Biopharmaceutical CDMO Service Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Biopharmaceutical CDMO Service Revenue (2018-2029) & (USD Million)
Figure 13. Biopharmaceutical CDMO Service Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Biopharmaceutical CDMO Service Consumption Value (2018-2029) & (USD Million)
Figure 16. World Biopharmaceutical CDMO Service Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Biopharmaceutical CDMO Service Consumption Value (2018-2029) & (USD Million)
Figure 18. China Biopharmaceutical CDMO Service Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Biopharmaceutical CDMO Service Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Biopharmaceutical CDMO Service Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Biopharmaceutical CDMO Service Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Biopharmaceutical CDMO Service Consumption Value (2018-2029) & (USD Million)
Figure 23. India Biopharmaceutical CDMO Service Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Biopharmaceutical CDMO Service by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Biopharmaceutical CDMO Service Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Biopharmaceutical CDMO Service Markets in 2022
Figure 27. United States VS China: Biopharmaceutical CDMO Service Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Biopharmaceutical CDMO Service Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Biopharmaceutical CDMO Service Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Biopharmaceutical CDMO Service Market Size Market Share by Type in 2022
Figure 31. Develop Innovative Drugs
Figure 32. Listed Patented Drug
Figure 33. Biosimilars
Figure 34. Others
Figure 35. World Biopharmaceutical CDMO Service Market Size Market Share by Type (2018-2029)
Figure 36. World Biopharmaceutical CDMO Service Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 37. World Biopharmaceutical CDMO Service Market Size Market Share by Application in 2022
Figure 38. Pharmaceutical Company
Figure 39. Biotechnology Company
Figure 40. Others
Figure 41. Biopharmaceutical CDMO Service Industrial Chain
Figure 42. Methodology
Figure 43. Research Process and Data Source
Table 1. World Biopharmaceutical CDMO Service Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Biopharmaceutical CDMO Service Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Biopharmaceutical CDMO Service Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Biopharmaceutical CDMO Service Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Biopharmaceutical CDMO Service Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Biopharmaceutical CDMO Service Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Biopharmaceutical CDMO Service Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Biopharmaceutical CDMO Service Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Biopharmaceutical CDMO Service Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Biopharmaceutical CDMO Service Players in 2022
Table 12. World Biopharmaceutical CDMO Service Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Biopharmaceutical CDMO Service Company Evaluation Quadrant
Table 14. Head Office of Key Biopharmaceutical CDMO Service Player
Table 15. Biopharmaceutical CDMO Service Market: Company Product Type Footprint
Table 16. Biopharmaceutical CDMO Service Market: Company Product Application Footprint
Table 17. Biopharmaceutical CDMO Service Mergers & Acquisitions Activity
Table 18. United States VS China Biopharmaceutical CDMO Service Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Biopharmaceutical CDMO Service Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Biopharmaceutical CDMO Service Companies, Headquarters (States, Country)
Table 21. United States Based Companies Biopharmaceutical CDMO Service Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Biopharmaceutical CDMO Service Revenue Market Share (2018-2023)
Table 23. China Based Biopharmaceutical CDMO Service Companies, Headquarters (Province, Country)
Table 24. China Based Companies Biopharmaceutical CDMO Service Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Biopharmaceutical CDMO Service Revenue Market Share (2018-2023)
Table 26. Rest of World Based Biopharmaceutical CDMO Service Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Biopharmaceutical CDMO Service Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Biopharmaceutical CDMO Service Revenue Market Share (2018-2023)
Table 29. World Biopharmaceutical CDMO Service Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Biopharmaceutical CDMO Service Market Size by Type (2018-2023) & (USD Million)
Table 31. World Biopharmaceutical CDMO Service Market Size by Type (2024-2029) & (USD Million)
Table 32. World Biopharmaceutical CDMO Service Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Biopharmaceutical CDMO Service Market Size by Application (2018-2023) & (USD Million)
Table 34. World Biopharmaceutical CDMO Service Market Size by Application (2024-2029) & (USD Million)
Table 35. KBI Biopharma Basic Information, Area Served and Competitors
Table 36. KBI Biopharma Major Business
Table 37. KBI Biopharma Biopharmaceutical CDMO Service Product and Services
Table 38. KBI Biopharma Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. KBI Biopharma Recent Developments/Updates
Table 40. KBI Biopharma Competitive Strengths & Weaknesses
Table 41. INCOG BioPharma Services Basic Information, Area Served and Competitors
Table 42. INCOG BioPharma Services Major Business
Table 43. INCOG BioPharma Services Biopharmaceutical CDMO Service Product and Services
Table 44. INCOG BioPharma Services Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. INCOG BioPharma Services Recent Developments/Updates
Table 46. INCOG BioPharma Services Competitive Strengths & Weaknesses
Table 47. CordenPharma Basic Information, Area Served and Competitors
Table 48. CordenPharma Major Business
Table 49. CordenPharma Biopharmaceutical CDMO Service Product and Services
Table 50. CordenPharma Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. CordenPharma Recent Developments/Updates
Table 52. CordenPharma Competitive Strengths & Weaknesses
Table 53. AGC Biologics Basic Information, Area Served and Competitors
Table 54. AGC Biologics Major Business
Table 55. AGC Biologics Biopharmaceutical CDMO Service Product and Services
Table 56. AGC Biologics Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. AGC Biologics Recent Developments/Updates
Table 58. AGC Biologics Competitive Strengths & Weaknesses
Table 59. Northway Biotech Basic Information, Area Served and Competitors
Table 60. Northway Biotech Major Business
Table 61. Northway Biotech Biopharmaceutical CDMO Service Product and Services
Table 62. Northway Biotech Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Northway Biotech Recent Developments/Updates
Table 64. Northway Biotech Competitive Strengths & Weaknesses
Table 65. PlantForm Corp Basic Information, Area Served and Competitors
Table 66. PlantForm Corp Major Business
Table 67. PlantForm Corp Biopharmaceutical CDMO Service Product and Services
Table 68. PlantForm Corp Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. PlantForm Corp Recent Developments/Updates
Table 70. PlantForm Corp Competitive Strengths & Weaknesses
Table 71. Lonza Basic Information, Area Served and Competitors
Table 72. Lonza Major Business
Table 73. Lonza Biopharmaceutical CDMO Service Product and Services
Table 74. Lonza Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Lonza Recent Developments/Updates
Table 76. Lonza Competitive Strengths & Weaknesses
Table 77. ADL Biopharma Basic Information, Area Served and Competitors
Table 78. ADL Biopharma Major Business
Table 79. ADL Biopharma Biopharmaceutical CDMO Service Product and Services
Table 80. ADL Biopharma Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. ADL Biopharma Recent Developments/Updates
Table 82. ADL Biopharma Competitive Strengths & Weaknesses
Table 83. Catalent Basic Information, Area Served and Competitors
Table 84. Catalent Major Business
Table 85. Catalent Biopharmaceutical CDMO Service Product and Services
Table 86. Catalent Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Catalent Recent Developments/Updates
Table 88. Catalent Competitive Strengths & Weaknesses
Table 89. Future Fields Basic Information, Area Served and Competitors
Table 90. Future Fields Major Business
Table 91. Future Fields Biopharmaceutical CDMO Service Product and Services
Table 92. Future Fields Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Future Fields Recent Developments/Updates
Table 94. Future Fields Competitive Strengths & Weaknesses
Table 95. Vetter Pharma Basic Information, Area Served and Competitors
Table 96. Vetter Pharma Major Business
Table 97. Vetter Pharma Biopharmaceutical CDMO Service Product and Services
Table 98. Vetter Pharma Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Vetter Pharma Recent Developments/Updates
Table 100. Vetter Pharma Competitive Strengths & Weaknesses
Table 101. Stelis Basic Information, Area Served and Competitors
Table 102. Stelis Major Business
Table 103. Stelis Biopharmaceutical CDMO Service Product and Services
Table 104. Stelis Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Stelis Recent Developments/Updates
Table 106. Stelis Competitive Strengths & Weaknesses
Table 107. Richter-Helm Basic Information, Area Served and Competitors
Table 108. Richter-Helm Major Business
Table 109. Richter-Helm Biopharmaceutical CDMO Service Product and Services
Table 110. Richter-Helm Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Richter-Helm Recent Developments/Updates
Table 112. Richter-Helm Competitive Strengths & Weaknesses
Table 113. FUJIFILM Diosynth Biotechnologies Basic Information, Area Served and Competitors
Table 114. FUJIFILM Diosynth Biotechnologies Major Business
Table 115. FUJIFILM Diosynth Biotechnologies Biopharmaceutical CDMO Service Product and Services
Table 116. FUJIFILM Diosynth Biotechnologies Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. FUJIFILM Diosynth Biotechnologies Recent Developments/Updates
Table 118. FUJIFILM Diosynth Biotechnologies Competitive Strengths & Weaknesses
Table 119. Cambrex Basic Information, Area Served and Competitors
Table 120. Cambrex Major Business
Table 121. Cambrex Biopharmaceutical CDMO Service Product and Services
Table 122. Cambrex Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Cambrex Recent Developments/Updates
Table 124. Cambrex Competitive Strengths & Weaknesses
Table 125. Pfizer CentreOne Basic Information, Area Served and Competitors
Table 126. Pfizer CentreOne Major Business
Table 127. Pfizer CentreOne Biopharmaceutical CDMO Service Product and Services
Table 128. Pfizer CentreOne Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Pfizer CentreOne Recent Developments/Updates
Table 130. Samsung Biologics Basic Information, Area Served and Competitors
Table 131. Samsung Biologics Major Business
Table 132. Samsung Biologics Biopharmaceutical CDMO Service Product and Services
Table 133. Samsung Biologics Biopharmaceutical CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 134. Global Key Players of Biopharmaceutical CDMO Service Upstream (Raw Materials)
Table 135. Biopharmaceutical CDMO Service Typical Customers
List of Figure
Figure 1. Biopharmaceutical CDMO Service Picture
Figure 2. World Biopharmaceutical CDMO Service Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Biopharmaceutical CDMO Service Total Market Size (2018-2029) & (USD Million)
Figure 4. World Biopharmaceutical CDMO Service Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Biopharmaceutical CDMO Service Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Biopharmaceutical CDMO Service Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Biopharmaceutical CDMO Service Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Biopharmaceutical CDMO Service Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Biopharmaceutical CDMO Service Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Biopharmaceutical CDMO Service Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Biopharmaceutical CDMO Service Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Biopharmaceutical CDMO Service Revenue (2018-2029) & (USD Million)
Figure 13. Biopharmaceutical CDMO Service Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Biopharmaceutical CDMO Service Consumption Value (2018-2029) & (USD Million)
Figure 16. World Biopharmaceutical CDMO Service Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Biopharmaceutical CDMO Service Consumption Value (2018-2029) & (USD Million)
Figure 18. China Biopharmaceutical CDMO Service Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Biopharmaceutical CDMO Service Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Biopharmaceutical CDMO Service Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Biopharmaceutical CDMO Service Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Biopharmaceutical CDMO Service Consumption Value (2018-2029) & (USD Million)
Figure 23. India Biopharmaceutical CDMO Service Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Biopharmaceutical CDMO Service by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Biopharmaceutical CDMO Service Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Biopharmaceutical CDMO Service Markets in 2022
Figure 27. United States VS China: Biopharmaceutical CDMO Service Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Biopharmaceutical CDMO Service Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Biopharmaceutical CDMO Service Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Biopharmaceutical CDMO Service Market Size Market Share by Type in 2022
Figure 31. Develop Innovative Drugs
Figure 32. Listed Patented Drug
Figure 33. Biosimilars
Figure 34. Others
Figure 35. World Biopharmaceutical CDMO Service Market Size Market Share by Type (2018-2029)
Figure 36. World Biopharmaceutical CDMO Service Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 37. World Biopharmaceutical CDMO Service Market Size Market Share by Application in 2022
Figure 38. Pharmaceutical Company
Figure 39. Biotechnology Company
Figure 40. Others
Figure 41. Biopharmaceutical CDMO Service Industrial Chain
Figure 42. Methodology
Figure 43. Research Process and Data Source
